These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 24374933)

  • 21. Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.
    Hernández Borrero LJ; El-Deiry WS
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188556. PubMed ID: 33932560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway.
    Joshi H; Bhanot G; Børresen-Dale AL; Kristensen V
    Br J Cancer; 2012 Nov; 107(10):1722-8. PubMed ID: 23079576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation.
    Szołtysek K; Janus P; Zając G; Stokowy T; Walaszczyk A; Widłak W; Wojtaś B; Gielniewski B; Cockell S; Perkins ND; Kimmel M; Widlak P
    BMC Genomics; 2018 Nov; 19(1):813. PubMed ID: 30419821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression.
    Indeglia A; Murphy ME
    Crit Rev Biochem Mol Biol; 2024; 59(1-2):128-138. PubMed ID: 38661126
    [No Abstract]   [Full Text] [Related]  

  • 25. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
    Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
    Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Na K; Sung JY; Kim HS
    Anticancer Res; 2017 Dec; 37(12):6697-6703. PubMed ID: 29187446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1.
    Li N; Zhang E; Li Z; Lv S; Zhao X; Ke Q; Zou Q; Li W; Wang Y; Guo H; Song T; Sun L
    J Biol Chem; 2024 Mar; 300(3):105707. PubMed ID: 38309505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potential of combating cancer by restoring wild-type p53 through mRNA nanodelivery.
    Kamath D; Iwakuma T; Bossmann SH
    Nanomedicine; 2024 Feb; 56():102732. PubMed ID: 38199451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
    Cheng LL; Itahana Y; Lei ZD; Chia NY; Wu Y; Yu Y; Zhang SL; Thike AA; Pandey A; Rozen S; Voorhoeve PM; Yu Q; Tan PH; Bay BH; Itahana K; Tan P
    Clin Cancer Res; 2012 Aug; 18(15):4201-12. PubMed ID: 22675170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Friend or Foe: MicroRNAs in the p53 network.
    Luo Z; Cui R; Tili E; Croce C
    Cancer Lett; 2018 Apr; 419():96-102. PubMed ID: 29330109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting mutant p53 for efficient cancer therapy.
    Bykov VJN; Eriksson SE; Bianchi J; Wiman KG
    Nat Rev Cancer; 2018 Feb; 18(2):89-102. PubMed ID: 29242642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence of cancer in mice.
    Brennan MS; Brinkmann K; Romero Sola G; Healey G; Gibson L; Gangoda L; Potts MA; Lieschke E; Wilcox S; Strasser A; Herold MJ; Janic A
    Cell Death Differ; 2024 Feb; 31(2):159-169. PubMed ID: 38110554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.
    Ishibashi M; Kogo R; Shibata K; Ueo H; Uchi R; Matsumura T; Takano Y; Sawada G; Takahashi Y; Mima K; Kurashige J; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Suzuki A; Wakabayashi G; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S537-44. PubMed ID: 23532381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p21(WAF1/CIP1) response to genotoxic agents in wild-type TP53 expressing breast primary tumours.
    Guillot C; Falette N; Paperin MP; Courtois S; Gentil-Perret A; Treilleux I; Ozturk M; Puisieux A
    Oncogene; 1997 Jan; 14(1):45-52. PubMed ID: 9010231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.
    Pappas K; Xu J; Zairis S; Resnick-Silverman L; Abate F; Steinbach N; Ozturk S; Saal LH; Su T; Cheung P; Schmidt H; Aaronson S; Hibshoosh H; Manfredi J; Rabadan R; Parsons R
    Mol Cancer Res; 2017 Aug; 15(8):1051-1062. PubMed ID: 28483946
    [No Abstract]   [Full Text] [Related]  

  • 37. Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis.
    McCubrey JA; Lertpiriyapong K; Fitzgerald TL; Martelli AM; Cocco L; Rakus D; Gizak A; Libra M; Cervello M; Montalto G; Yang LV; Abrams SL; Steelman LS
    Adv Biol Regul; 2017 Jan; 63():32-48. PubMed ID: 27776972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma.
    Sun H; Liu SY; Zhou JY; Xu JT; Zhang HK; Yan HH; Huan JJ; Dai PP; Xu CR; Su J; Guan YF; Yi X; Yu RS; Zhong WZ; Wu YL
    EBioMedicine; 2020 Oct; 60():102990. PubMed ID: 32927274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.
    Nyiraneza C; Jouret-Mourin A; Kartheuser A; Camby P; Plomteux O; Detry R; Dahan K; Sempoux C
    Hum Pathol; 2011 Dec; 42(12):1897-910. PubMed ID: 21665242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, causes and impact of TP53-loss phenocopying events in human tumors.
    Fito-Lopez B; Salvadores M; Alvarez MM; Supek F
    BMC Biol; 2023 Apr; 21(1):92. PubMed ID: 37095494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.